Peer Review History

Original SubmissionFebruary 25, 2021
Decision Letter - Mária A. Deli, Editor

PONE-D-21-06276

Caco-2/HT29-MTX co-cultured cells as a model for studying physiological properties and toxin-induced effects on intestinal cells

PLOS ONE

Dear Dr. Hoffmann,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses all the points raised during the review process.

Two experts have evaluated the manuscript and found it of interest for the field, but needs amendments at several parts. There might be some technical problems with the permeability measurements (extensive dilution of the samples?) which need to be repeated for the meaningful characterization of the model. The same is true for the junctional stainings. 

Please submit your revised manuscript by Jun 11 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Mária A. Deli, M.D., Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. PLOS ONE now requires that authors provide the original uncropped and unadjusted images underlying all blot or gel results reported in a submission’s figures or Supporting Information files. This policy and the journal’s other requirements for blot/gel reporting and figure preparation are described in detail at https://journals.plos.org/plosone/s/figures#loc-blot-and-gel-reporting-requirements and https://journals.plos.org/plosone/s/figures#loc-preparing-figures-from-image-files. When you submit your revised manuscript, please ensure that your figures adhere fully to these guidelines and provide the original underlying images for all blot or gel data reported in your submission. See the following link for instructions on providing the original image data: https://journals.plos.org/plosone/s/figures#loc-original-images-for-blots-and-gels.

In your cover letter, please note whether your blot/gel image data are in Supporting Information or posted at a public data repository, provide the repository URL if relevant, and provide specific details as to which raw blot/gel images, if any, are not available. Email us at plosone@plos.org if you have any questions.

3. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: In this manuscript Hoffmann and colleagues described and characterized a co-culture model of the human intestinal Caco-2 epithelial and the mucus producing HT29-MTX goblet cell lines which is a good cell combination for investigating the molecular mechanisms of various enterotoxins. The cholera toxin and heat-labile enterotoxin show structural similarity and cause electrophysiological changes (Cl- outflow) in the human intestinal barrier that leads to diarrhea. The effect of these toxins was tested on their barrier model and the electrophysiological changes were characterized by sort-circuit current. As a novelty, they used the Ussing chamber technique to characterize this intestinal model, in which the cell layers form mechanical and functional barriers. Using this system, the electrophysiological and structural changes can be measured simultaneously. Although the present study is of interest for the field, there are several points which need to be clarified, especially the characterization of co-co-culture model using Ussing chamber and better explanation of the short-circuit current technique.

Comments:

1. For the introduction:

I suggest the authors to add more detail about the background of the Ussing chamber and the “short-circuit current” technique, why was this method chosen, what are the advantages and its importance. Please also describe the mechanism of the investigated toxins. A justification is also needed for the selection of the studied transporters.

In addition, since the message of the present study is to highlight the connection between toxin effect and the cellular electrophysiological changes by measuring short-circuit current condition, a short description on the effect of toxins and ion transporters would be needed for a better understanding of the significance of the research for the larger public.

2. The Caco-2 epithelial cell line forms a tight barrier resulting in low paracellular permeability for several marker molecules. Lucifer yellow (LY) was used in the present study as a paracellular marker to assess the tightness of the barrier model. The molecular weight of LY is small (444 Da) and the incubation time was quite long (9 hours), so it is hard to understand the result that “no paracellular transport was detected”. Based on the literature an apparent permeability coefficient in the range of 10-6 to 10-7 cm/s should be obtained on a similar model. I suggest to repeat this experiment with a better fluorescence spectroscopy detection technique. It is also suggested to use higher sample volumes from the basolateral chamber (full volume at the end of the experiment) without any further dilution. For the full characterization of a new model it is important to give the exact parameters of the paracellular permeability (eg. apparent permeability coefficient).

3. Immunofluorescence staining was performed for ZO-1 to prove the presence of tight junctions (TJs) between cells. While ZO-1, a junctional associated protein and a cytoplasmic linker between transmembrane TJ proteins and actin cytoskeleton, is accepted to indicate the presence of intercellular junctions, staining for integral membrane TJ proteins occludin or claudins would be better indicators of the presence of tight interepithelial junctions. TJ staining should be performed on monocultures, not just on co-culture to complete the TEER and immunohistochemical data.

Minor suggestions:

1. In line 99 a half bracket and in line 103 an empty bracket should be removed.

2. The word “briefly” occurs 4 times in the methods section. This word should be omitted, since this section must be as detailed as possible in a research article. The journal policy also supports full description of methods for reproducibility.

3. Figure 2: please replace the image of D28 for co-culture. It does not represent a layer. Also, the membrane is not visible in contrast to all other images.

4. Figure 8: a densitometry is needed to evaluate the WB changes.

Reviewer #2: I would like to note to the authors some differences in nomenclature, spelling, and notation:

In 43- line: “unreported cases are estimated (2) Another” the punctuation mark at the end of the sentence is missing.

In 103- line: “DMEM () was added” the origin of the substance is missing in bracket.

In 121- line: “aqua destillata” if you use the official latin name, or trade name then Aqua destillata or in English distilled water.

In 274- line and in “Ussing chamber studies” result part the authors use Ω * cm2 notation, but previously and in other chapters used Ω x cm2.

In 284-line authors use adenylyl cyclase name, previously in 356 line used adenylate cyclase. It would be obvious to use only one synonym because it can be misleading.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Dr. Alexandra Bocsik

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

The authors thank the reviewers for their time and efforts to review this manuscript giving us the opportunity to further enhance the quality of this study by adding useful comments.

Reviewer #1: In this manuscript Hoffmann and colleagues described and characterized a co-culture model of the human intestinal Caco-2 epithelial and the mucus producing HT29-MTX goblet cell lines which is a good cell combination for investigating the molecular mechanisms of various enterotoxins. The cholera toxin and heat-labile enterotoxin show structural similarity and cause electrophysiological changes (Cl- outflow) in the human intestinal barrier that leads to diarrhea. The effect of these toxins was tested on their barrier model and the electrophysiological changes were characterized by sort-circuit current. As a novelty, they used the Ussing chamber technique to characterize this intestinal model, in which the cell layers form mechanical and functional barriers. Using this system, the electrophysiological and structural changes can be measured simultaneously. Although the present study is of interest for the field, there are several points which need to be clarified, especially the characterization of co-co-culture model using Ussing chamber and better explanation of the short-circuit current technique.

Comments:

1. For the introduction:

I suggest the authors to add more detail about the background of the Ussing chamber and the “short-circuit current” technique, why was this method chosen, what are the advantages and its importance. Please also describe the mechanism of the investigated toxins. A justification is also needed for the selection of the studied transporters.

In addition, since the message of the present study is to highlight the connection between toxin effect and the cellular electrophysiological changes by measuring short-circuit current condition, a short description on the effect of toxins and ion transporters would be needed for a better understanding of the significance of the research for the larger public.

The characteristic effects of the enterotoxins and their influence on the CFTR have been described in more detail in the introduction (lines 48-60), thus justifying the analysis of this transporter, in addition to an overview of the Ussing chamber methodology being added to the introductory section (lines 87-92). Finally, the focus on the SGLT1 and PepT1-transporter as characteristic examples for epithelial transport proteins of the small intestines was specified in the discussion (lines 411-413).

2. The Caco-2 epithelial cell line forms a tight barrier resulting in low paracellular permeability for several marker molecules. Lucifer yellow (LY) was used in the present study as a paracellular marker to assess the tightness of the barrier model. The molecular weight of LY is small (444 Da) and the incubation time was quite long (9 hours), so it is hard to understand the result that “no paracellular transport was detected”. Based on the literature an apparent permeability coefficient in the range of 10-6 to 10-7 cm/s should be obtained on a similar model. I suggest to repeat this experiment with a better fluorescence spectroscopy detection technique. It is also suggested to use higher sample volumes from the basolateral chamber (full volume at the end of the experiment) without any further dilution. For the full characterization of a new model it is important to give the exact parameters of the paracellular permeability (eg. apparent permeability coefficient).

The cells for this experimental approach were cultivated on a membrane with 0,4 µm pore size, which impairs the transport capacity more when compared to the more frequently used membranes with a 3 µm pore size . The high TEER values obtained in the present study imply a high cell-to-cell connection, which results in decreased paracellular transport and thus lower Papp values. In addition, we intentionally opted for a cultivation of cells on membranes with 3 µm pores, in order to be able to compare the results with those obtained in the Ussing chamber experiments. Generally, the non-detectable transport of Lucifer Yellow (LY) after an incubation period of 9 hours shows the high integrity of the cellular layer, resulting in transport processes observed in the Ussing chamber setup being attributable to trans- rather than paracellular transport mechanisms. In order to show that the LY transport assay was correctly performed, a representative evaluation of one LY experiment is attached for review, in which it is shown that all measured values are within the linear range of the assay. In addition, as indicated in the manuscript, the assay was performed in accordance with the following publication: Willenberg, Michael et al. (2015). In conclusion, the non-detectable paracellular transport of LY is intentional and desirable in the frame of the present study, as this allows the analysis of transcellular transport processes only.

3. Immunofluorescence staining was performed for ZO-1 to prove the presence of tight junctions (TJs) between cells. While ZO-1, a junctional associated protein and a cytoplasmic linker between transmembrane TJ proteins and actin cytoskeleton, is accepted to indicate the presence of intercellular junctions, staining for integral membrane TJ proteins occludin or claudins would be better indicators of the presence of tight interepithelial junctions. TJ staining should be performed on monocultures, not just on co-culture to complete the TEER and immunohistochemical data.

To give a broader insight in the expression of ZO-1, stainings of Caco-2 and Ht29-MTX monocultures were added to the manuscript and the Figure 3 was changed accordingly (lines 232-238; 267-275; 375-381). To keep the focus on the functional aspects of this study only ZO-1 staining as tight-junction associated protein was performed as it has been shown that ZO-1 directly correlates with higher expression of tight junction proteins and increasing TEER values (Dolan, Naughton et al. 2012, Chang, Liang et al. 2020, Reale, Huguet et al. 2021).

Minor suggestions:

1. In line 99 a half bracket and in line 103 an empty bracket should be removed.

The text was corrected accordingly.

2. The word “briefly” occurs 4 times in the methods section. This word should be omitted, since this section must be as detailed as possible in a research article. The journal policy also supports full description of methods for reproducibility.

The word has been omitted and the full description of the used method is given.

3. Figure 2: please replace the image of D28 for co-culture. It does not represent a layer. Also, the membrane is not visible in contrast to all other images.

The respective image has been replaced and a new figure (Figure 8) was created.

4. Figure 8: a densitometry is needed to evaluate the WB changes.

A densitometrical analysis was performed (lines 181-182; 243-245; 343-360) and the respective figure added as Figure 9 to the manuscript. Furthermore, the materials & methods section was updated with information on densitometrical and statistical analysis of the protein expression. Results of the analysis were incorporated in the results and the discussion sections.

Reviewer #2: I would like to note to the authors some differences in nomenclature, spelling, and notation:

In 43- line: “unreported cases are estimated (2) Another” the punctuation mark at the end of the sentence is missing.

In 103- line: “DMEM () was added” the origin of the substance is missing in bracket.

In 121- line: “aqua destillata” if you use the official latin name, or trade name then Aqua destillata or in English distilled water.

In 274- line and in “Ussing chamber studies” result part the authors use Ω * cm2 notation, but previously and in other chapters used Ω x cm2.

In 284-line authors use adenylyl cyclase name, previously in 356 line used adenylate cyclase. It would be obvious to use only one synonym because it can be misleading.

All the above-mentioned comments regarding nomenclature, spelling and notation have been taken into account and changed accordingly in the manuscript.

Chang, Y.-N., Y. Liang, S. Xia, X. Bai, J. Zhang, J. Kong, K. Chen, J. Li and G. Xing (2020). "The High Permeability of Nanocarriers Crossing the Enterocyte Layer by Regulation of the Surface Zonal Pattern." Molecules (Basel, Switzerland) 25(4): 919.

Dolan, B., J. Naughton, N. Tegtmeyer, F. E. B. May and M. Clyne (2012). "The Interaction of Helicobacter pylori with the Adherent Mucus Gel Layer Secreted by Polarized HT29-MTX-E12 Cells." PLOS ONE 7(10): e47300.

Reale, O., A. Huguet and V. Fessard (2021). "Co-culture model of Caco-2/HT29-MTX cells: A promising tool for investigation of phycotoxins toxicity on the intestinal barrier." Chemosphere 273: 128497.

Willenberg, I., M. Michael, J. Wonik, L. C. Bartel, M. T. Empl and N. H. Schebb (2015). "Investigation of the absorption of resveratrol oligomers in the Caco-2 cellular model of intestinal absorption." Food Chem 167: 245-250.

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Mária A. Deli, Editor

Caco-2/HT29-MTX co-cultured cells as a model for studying physiological properties and toxin-induced effects on intestinal cells

PONE-D-21-06276R1

Dear Dr. Hoffmann,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Mária A. Deli, M.D., Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

I trust the authors to correct the figure legend, as requested by the reviewer, during the final proofreading of their manuscript.

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Formally Accepted
Acceptance Letter - Mária A. Deli, Editor

PONE-D-21-06276R1

Caco-2/HT29-MTX co-cultured cells as a model for studying physiological properties and toxin-induced effects on intestinal cells

Dear Dr. Hoffmann:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Mária A. Deli

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .